Harry S. Palmin - Novelos Therapeutics, Inc. (nvlt) - The Wall Street Transcript

The Wall Street Transcript - In-Depth Interviews for Investors

Healthcare >> CEO Interviews >> August 20, 2007

TWST: What is Novelos Therapeutics?

Mr. Palmin: Novelos Therapeutics is in a pivotal Phase III trial for lung cancer

under SPA and Fast Track. We have several Phase IIs that are also ongoing

Join for free to read a longer excerpt or purchase this article